CN103189356B - N-杂芳基化合物 - Google Patents

N-杂芳基化合物 Download PDF

Info

Publication number
CN103189356B
CN103189356B CN201180052605.XA CN201180052605A CN103189356B CN 103189356 B CN103189356 B CN 103189356B CN 201180052605 A CN201180052605 A CN 201180052605A CN 103189356 B CN103189356 B CN 103189356B
Authority
CN
China
Prior art keywords
alkyl
hydrogen
amino
group
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201180052605.XA
Other languages
English (en)
Chinese (zh)
Other versions
CN103189356A (zh
Inventor
M.贝格尔
C.柯恩
M.埃克
J.施勒德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Original Assignee
Intervet International BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet International BV filed Critical Intervet International BV
Priority to CN201510648665.8A priority Critical patent/CN105294549B/zh
Publication of CN103189356A publication Critical patent/CN103189356A/zh
Application granted granted Critical
Publication of CN103189356B publication Critical patent/CN103189356B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C07D215/46—Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Quinoline Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN201180052605.XA 2010-09-29 2011-09-28 N-杂芳基化合物 Expired - Fee Related CN103189356B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510648665.8A CN105294549B (zh) 2010-09-29 2011-09-28 N‑杂芳基化合物

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP10181553.8 2010-09-29
EP10181553 2010-09-29
US38846610P 2010-09-30 2010-09-30
US61/388466 2010-09-30
PCT/EP2011/066806 WO2012041873A1 (en) 2010-09-29 2011-09-28 N-heteroaryl compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201510648665.8A Division CN105294549B (zh) 2010-09-29 2011-09-28 N‑杂芳基化合物

Publications (2)

Publication Number Publication Date
CN103189356A CN103189356A (zh) 2013-07-03
CN103189356B true CN103189356B (zh) 2015-11-25

Family

ID=44719930

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201180052605.XA Expired - Fee Related CN103189356B (zh) 2010-09-29 2011-09-28 N-杂芳基化合物
CN201510648665.8A Expired - Fee Related CN105294549B (zh) 2010-09-29 2011-09-28 N‑杂芳基化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201510648665.8A Expired - Fee Related CN105294549B (zh) 2010-09-29 2011-09-28 N‑杂芳基化合物

Country Status (17)

Country Link
US (1) US8877934B2 (enExample)
EP (1) EP2621903B1 (enExample)
JP (1) JP5791725B2 (enExample)
KR (1) KR101916481B1 (enExample)
CN (2) CN103189356B (enExample)
AR (1) AR083200A1 (enExample)
AU (1) AU2011310592B2 (enExample)
BR (1) BR112013006030B1 (enExample)
CA (1) CA2811369C (enExample)
CO (1) CO6710926A2 (enExample)
ES (1) ES2622881T3 (enExample)
HU (1) HUE034042T2 (enExample)
MX (1) MX340985B (enExample)
NZ (1) NZ607580A (enExample)
PL (1) PL2621903T3 (enExample)
RU (1) RU2596185C2 (enExample)
WO (1) WO2012041873A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10096073B2 (en) 2011-05-13 2018-10-09 The Climate Corporation Systems to prescribe and deliver fertilizer over agricultural fields and related methods
US10842144B2 (en) * 2011-05-13 2020-11-24 The Climate Corporation Method and system to map biological pests in agricultural fields using remotely-sensed data for field scouting and targeted chemical application
EP2831042B1 (en) * 2012-03-28 2019-07-31 Intervet International B.V. Heteroaryl compounds with a-cyclic bridging unit
WO2014093591A1 (en) * 2012-12-13 2014-06-19 Dow Agrosciences Llc Processes for the preparation of 4-amino-3-halo-6- (substituted)picolinates and 4-amino-5-fluoro-3-halo-6- (substituted)picolinates
RU2653855C2 (ru) * 2012-12-13 2018-05-15 ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи Способ получения 4-амино-5-фтор-3-хлор-6-(замещенных)пиколинатов
WO2015177179A1 (en) 2014-05-21 2015-11-26 Intervet International B.V. Improved process for preparing substituted crotonic acids
MY195016A (en) 2014-08-04 2023-01-03 Nuevolution As Optionally Fused Heterocyclyl-Substituted Derivatives of Pyrimidine Useful for The Treatment of Inflammatory, Metabolic, Oncologic and Autoimmune Diseases
RU2018126762A (ru) * 2015-12-23 2020-01-23 Интервет Интернэшнл Б.В. Улучшенный способ получения кротониламинопиридинов
AR111260A1 (es) 2017-03-31 2019-06-19 Intervet Int Bv Formulación farmacéutica de la sal de crotonil amino piridina
WO2020128020A2 (de) * 2018-12-21 2020-06-25 Saltigo Gmbh Verfahren zur herstellung von 2-alkoxy-4-amino-5-methyl-pyridinen und/oder von 2-alkoxy-4-alkylamino-5-methyl-pyridinen
MX2022007671A (es) 2019-12-18 2022-07-19 Intervet Int Bv Compuestos antihelminticos que comprenden una estructura de azaindoles.
AU2020405446A1 (en) 2019-12-20 2022-05-26 Nuevolution A/S Compounds active towards nuclear receptors
BR112022012205A2 (pt) 2019-12-20 2022-09-13 Nuevolution As Compostos ativos para receptores nucleares
CN110960485B (zh) * 2020-01-06 2021-02-02 安丘市人民医院 一种用于治疗角膜炎的药物及其制备方法
JP7713954B2 (ja) 2020-03-31 2025-07-28 ヌエヴォリューション・アクティーゼルスカブ 核内受容体に対して活性な化合物
CA3174252A1 (en) 2020-03-31 2021-10-07 Nuevolution A/S Compounds active towards nuclear receptors
CN122555710A (zh) * 2024-01-15 2026-08-11 上海瑛派药业有限公司 Wee1抑制剂的晶型及其制备方法

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2758036A1 (de) * 1977-12-24 1979-07-05 Boehringer Mannheim Gmbh Adsorbens fuer die affinitaetsspezifische trennung von makromolekularen stoffen, verfahren zu seiner herstellung und seine verwendung
WO1997048696A1 (en) * 1996-06-20 1997-12-24 Klinge Pharma Gmbh Pyridyl alkene- and pyridyl alkine- acid amides as cytostatics and immunosuppressives
WO1997048397A1 (en) * 1996-06-20 1997-12-24 Klinge Pharma Gmbh Use of pyridyl alkane, pyridyl alkene and/or pyridyl alkine acid amides in the treatment of tumors or for immunosuppression
US20060147847A1 (en) * 2004-12-30 2006-07-06 Guire Patrick E Antimicrobial compositions and methods
EP1900772A2 (de) * 2006-08-22 2008-03-19 Henkel Kommanditgesellschaft auf Aktien Formfixierung faserhaltiger Materialien durch Polymere
CN101284812A (zh) * 2008-06-05 2008-10-15 中山大学 他克林-阿魏酸杂联体,其制备方法及其药物组合物
CN101472904A (zh) * 2006-04-20 2009-07-01 弗·哈夫曼-拉罗切有限公司 趋化因子受体的二氮杂环庚烷衍生物调节剂

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1131225A (en) * 1977-03-02 1982-09-07 Werner Muller Dyestuffs as affine residues
DE2709094C2 (de) * 1977-03-02 1984-11-22 Boehringer Mannheim Gmbh, 6800 Mannheim Adsorbens für die affinitätsspezifische Trennung von Nukleinsäuren, Verfahren zu seiner Herstellung und seine Verwendung
US5098462A (en) 1985-08-20 1992-03-24 Sandoz Ltd. Substituted semi-carbazones and related compounds
WO1992000964A1 (fr) 1990-07-05 1992-01-23 Nippon Soda Co., Ltd. Derive d'amine
JP2986187B2 (ja) * 1990-08-31 1999-12-06 コニカ株式会社 感熱転写材料による画像形成方法
FR2683817B1 (fr) * 1991-11-18 1994-02-25 Upsa Laboratoires Nouveaux derives d'alpha-amino n-pyridyl benzene propanamide, leurs procedes de preparation, compositions pharmaceutiques les contenant.
US5399582A (en) 1993-11-01 1995-03-21 Merck & Co., Inc. Antiparasitic agents
US6221894B1 (en) 1995-03-20 2001-04-24 Merck & Co., Inc. Nodulisporic acid derivatives
US5595991A (en) 1995-03-20 1997-01-21 Merck & Co., Inc. Anthelmintic use of nodulisporic acid and analogs thereof
CN1082814C (zh) 1995-03-20 2002-04-17 麦克公司 球孢子酸衍生物
US5962499A (en) 1995-03-20 1999-10-05 Merck & Co., Inc. Nodulisporic acid derivatives
US6017919A (en) * 1996-02-06 2000-01-25 Japan Tobacco Inc. Compounds and pharmaceutical use thereof
US5834260A (en) 1996-08-30 1998-11-10 Merck & Co., Inc. Antiparasitic agents
UA77200C2 (en) 2001-08-07 2006-11-15 Wyeth Corp Antineoplastic combination of cci-779 and bkb-569
CA2467718C (en) * 2001-12-21 2011-04-26 Anormed Inc. Chemokine receptor binding heterocyclic compounds with enhanced efficacy
TW200418863A (en) * 2002-10-17 2004-10-01 Upjohn Co Novel anthelmintic and insecticidal compositions
KR100470076B1 (ko) 2002-11-27 2005-02-05 씨제이 주식회사 1,2,4-트리아졸 유도체, 그 제조방법 및 약제학적 조성물
US20060040931A1 (en) 2002-12-06 2006-02-23 Toray Industries, Inc. Benzomorpholine derivatives
CA2551867C (en) 2003-12-31 2010-08-17 Schering-Plough Ltd. Control of parasites in animals by the use of imidazo[1,2-b]pyridazine derivatives
WO2005066119A2 (en) 2003-12-31 2005-07-21 Schering-Plough Ltd. Antibacterial 1-(4-mono-and di-halomethylsulphonylphenyl)-2-acylamino-3-fluoropropanols and preparation thereof
BRPI0508140B1 (pt) 2004-03-05 2015-03-17 Nissan Chemical Ind Ltd Composto benzamida substituída por isoxazolina da fórmula (1); da fórmula (2) substituído por 3,5-bis (aril substituído); da fórmula (4) substituída por alquinibenzeno ou um sal do mesmo; "pesticida, agroquímico, inseticida, parasiticida contendo como ingrediente ativo um ou mais composto benzamida substituída por isoxazolina e sal do mesmo"
WO2006010084A2 (en) * 2004-07-06 2006-01-26 Segev Laboratories Limited A system for delivering therapeutic agents into living cells and cell nuclei
DE602005009381D1 (de) 2004-09-23 2008-10-09 Schering Plough Ltd Bekämpfung von parasiten in tieren durch verwendung neuer trifluormethansulfonanilidoximetherderivate
JP4750126B2 (ja) 2004-11-19 2011-08-17 シェーリング−プラウ・リミテッド 殺寄生虫薬２−フェニル−３−（１ｈ−ピロール−２−イル）アクリロニトリル誘導体の使用による動物における寄生虫の制御
US7700597B2 (en) 2004-12-03 2010-04-20 Schering Corporation Substituted piperazines as CB1 antagonists
CN101175729B (zh) * 2004-12-07 2011-06-01 梅瑞尔有限公司 1-苯基-3-哌嗪-吡唑及其杀虫组合物
WO2006105056A2 (en) * 2005-03-28 2006-10-05 Fmc Corporation Insecticidal 2,4-diaminoquinazolines and related derivatives
RU2007140957A (ru) 2005-05-25 2009-06-27 Вайет (Us) Способы синтеза производных 6-алкиламинохинолинов
EP1890547A2 (en) 2005-06-09 2008-02-27 Schering-Plough Ltd. Control of parasites in animals by n-[(phenyloxy)phenyl]-1,1,1-trifluoromethanesulfonamide and n-[(phenylsulfanyl)phenyl]-1,1,1-trifluoromethanesulfonamide derivatives
BRPI0617076B1 (pt) 2005-09-02 2021-07-06 Nissan Chemical Corporation Composto benzamida substituída por isoxazolina da fórmula (1) ou sal do mesmo; composto benzamida substituido por 4-hidroxiiminametila da fórmula (2) ou sal do mesmo; pesticida; agente agroquímico; parasiticida interno ou externo para mamíferos ou aves; inseticida ou acaricida
EP1965645A2 (en) 2005-12-14 2008-09-10 E.I. Du Pont De Nemours And Company Isoxazolines for controlling invertebrate pests
TW200803740A (en) 2005-12-16 2008-01-16 Du Pont 5-aryl isoxazolines for controlling invertebrate pests
TWI412322B (zh) 2005-12-30 2013-10-21 杜邦股份有限公司 控制無脊椎害蟲之異唑啉
EP1997813B1 (en) 2006-03-10 2010-05-05 Nissan Chemical Industries, Ltd. Substituted isoxazoline compound and pest control agent
DE102006015470A1 (de) 2006-03-31 2007-10-04 Bayer Cropscience Ag Substituierte Enaminocarbonylverbindungen
JPWO2007125984A1 (ja) 2006-04-28 2009-09-10 日本農薬株式会社 イソキサゾリン誘導体及び有害生物防除剤並びにその使用方法
JP2008044880A (ja) 2006-08-15 2008-02-28 Bayer Cropscience Ag 殺虫性イソオキサゾリン類
EP1903038A1 (de) 2006-09-07 2008-03-26 Bayer Schering Pharma Aktiengesellschaft N-(1-Hetaryl-piperidin-4-yl)-(het)arylamide als EP2-Rezeptor Modulatoren
EP1900731A1 (de) 2006-09-07 2008-03-19 Bayer Schering Pharma Aktiengesellschaft N-(1-Phthalazin-1-yl-piperidin-4-yl)-amide als EP2-Rezeptor Modulatoren
NZ580241A (en) 2007-04-10 2011-02-25 Bayer Cropscience Ag Insecticidal aryl isoxazoline derivatives
US20100130496A1 (en) 2007-04-12 2010-05-27 F. Hoffmann-La Roche Ag Pyrimidine derivatives as inhibitors of phosphatidylinositol-3-kinase
TW200900398A (en) 2007-05-31 2009-01-01 Du Pont 3-cyano-4-triazolyl phenylisoxazoline invertebrate pest control agents
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
DK2182945T3 (en) 2007-06-27 2015-11-16 Du Pont PROCEDURE TO COMBAT PESTS WITH ANIMALS
US8288393B2 (en) 2007-08-10 2012-10-16 Nippon Soda Co., Ltd. Nitrogen-containing heterocyclic compound and pest control agent
JP5365806B2 (ja) 2007-09-10 2013-12-11 日産化学工業株式会社 置換イソキサゾリン化合物及び有害生物防除剤
US8367584B2 (en) 2007-10-03 2013-02-05 E.I. Du Pont De Nemours And Company Naphthalene isoxazoline compounds for control of invertebrate pests
WO2009051956A2 (en) 2007-10-16 2009-04-23 E. I. Du Pont De Nemours And Company Pyrazole-substituted isoxazoline insecticides
US8809268B2 (en) 2008-10-29 2014-08-19 The Regents Of The University Of California Combination therapy to combat helminth resistance
US8007761B2 (en) 2008-12-24 2011-08-30 Praxair Technology, Inc. Carbon dioxide emission reduction method

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2758036A1 (de) * 1977-12-24 1979-07-05 Boehringer Mannheim Gmbh Adsorbens fuer die affinitaetsspezifische trennung von makromolekularen stoffen, verfahren zu seiner herstellung und seine verwendung
WO1997048696A1 (en) * 1996-06-20 1997-12-24 Klinge Pharma Gmbh Pyridyl alkene- and pyridyl alkine- acid amides as cytostatics and immunosuppressives
WO1997048397A1 (en) * 1996-06-20 1997-12-24 Klinge Pharma Gmbh Use of pyridyl alkane, pyridyl alkene and/or pyridyl alkine acid amides in the treatment of tumors or for immunosuppression
US20060147847A1 (en) * 2004-12-30 2006-07-06 Guire Patrick E Antimicrobial compositions and methods
CN101472904A (zh) * 2006-04-20 2009-07-01 弗·哈夫曼-拉罗切有限公司 趋化因子受体的二氮杂环庚烷衍生物调节剂
EP1900772A2 (de) * 2006-08-22 2008-03-19 Henkel Kommanditgesellschaft auf Aktien Formfixierung faserhaltiger Materialien durch Polymere
CN101284812A (zh) * 2008-06-05 2008-10-15 中山大学 他克林-阿魏酸杂联体,其制备方法及其药物组合物

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
RN：1008128-81-1、1008128-82-2、1008128-83-3、1008128-84-4、1008128-85-5、1008128-86-6;ACS;《STN Registry数据库》;20080316;参见CAS号：1008128-81-1、1008128-82-2、1008128-83-3、1008128-84-4、1008128-85-5、1008128-86-6 *
RN：31672-61-4、69631-09-0;ACS;《STN Registry数据库》;19841116;参见CAS号：31672-61-4、69631-09-0 *
Safety-Catch Approach to Orthogonal Synthesis of a Triazine Library;Sonya M. K.等;《Journal of Combinatorial Chemistry》;20040423;第6卷(第4期);第475、476页 *
Synthesis and pharmacological testing of polyaminoquinolines as blockers of the apamin-sensitive Ca2+-activated K+ channel (SKCa);David I.F.等;《Bioorganic & Medicinal Chemistry》;20070526;第15卷(第16期);第5466页流程图4 *

Also Published As

Publication number Publication date
AU2011310592A1 (en) 2013-03-14
KR101916481B1 (ko) 2018-11-07
CA2811369C (en) 2019-09-03
US20130196993A1 (en) 2013-08-01
CN105294549A (zh) 2016-02-03
CA2811369A1 (en) 2012-04-05
WO2012041873A1 (en) 2012-04-05
EP2621903B1 (en) 2017-03-01
RU2013119681A (ru) 2014-11-10
AR083200A1 (es) 2013-02-06
AU2011310592B2 (en) 2015-01-22
ES2622881T3 (es) 2017-07-07
CN105294549B (zh) 2017-12-26
CO6710926A2 (es) 2013-07-15
KR20130139889A (ko) 2013-12-23
HUE034042T2 (en) 2018-01-29
CN103189356A (zh) 2013-07-03
BR112013006030B1 (pt) 2020-03-17
BR112013006030A2 (pt) 2016-06-07
PL2621903T3 (pl) 2017-08-31
MX340985B (es) 2016-08-01
EP2621903A1 (en) 2013-08-07
MX2013003635A (es) 2013-05-22
RU2596185C2 (ru) 2016-08-27
JP2014500235A (ja) 2014-01-09
JP5791725B2 (ja) 2015-10-07
US8877934B2 (en) 2014-11-04
NZ607580A (en) 2015-01-30

Similar Documents

Publication Publication Date Title
CN105294549B (zh) N‑杂芳基化合物
ES2624845T3 (es) Compuestos de N-heteroarilo con unidad de puente cíclico para el tratamiento de enfermedades parasitarias
US12509449B2 (en) Anthelmintic compounds comprising a quinoline structure
US12479841B2 (en) Anthelmintic compounds comprising azaindoles structure
CZ20003982A3 (cs) Imidazopyridinové deriváty inhibující sekreci žaludeční kyseliny
CN115667221A (zh) 作为驱虫化合物的取代的稠合嗪类
US20240043446A1 (en) Anthelmintic compounds comprising a thienopyridine structure
AU2017248514B2 (en) Heteroaryl compounds with a-cyclic bridging unit
US9096599B2 (en) Spiroindoline compounds
US9598412B2 (en) Spiroindoline compounds for use as anthelminthics
WO2020002593A1 (en) Compound for use against helminthic infection
CA3057254A1 (en) Pharmaceutical formulation of crotonylaminopyridine salt

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20151125

Termination date: 20210928

CF01 Termination of patent right due to non-payment of annual fee